Scientists think there is one cause behind worrying rise of lung cancer in people that have never smoked
Scientists believe that air pollution could be a major cause behind the rise in global lung cancer cases in people that have ...
The American Journal of Managed Care12d
5 Potential Therapeutic Targets for Small Cell Lung Cancer
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
The American Journal of Managed Care15d
Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
Hosted on MSN8mon
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Shares of Summit Therapeutics Inc. jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc.’s blockbuster Keytruda in a late-stage ...
Nature23d
Non-small-cell lung cancer articles from across Nature Portfolio
Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.
Hosted on MSN10mon
Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows
In January, Novocure announced that its Premarket Approval application seeking approval for TTFields therapy with standard systemic therapies for non-small cell lung cancer, following progression ...
Pharm Exec13d
ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...